Author:
Malacco E.,Magni Alberto,Scandiani L.,Casini A.,Albano S.,Ansuini R.,Biasion T.,Biffi E.,Bilardo G.,Boccuzzi G.,Breda E.,Buttafarro A.,Chella P. S.,Chieffo C.,Coletta D.,Coli L.,Colombo L.,Compagnoni A.,D’Amico G.,D’Ascia C.,Gregori M.,Joannon U.,Distante R.,Donadon V.,Donnini P.,Fallucca F.,Ferrari L.,Fesce E.,Formoso L.,Furlani M.,Galetta F.,Gianni R.,Giustina G.,Irace L.,Lipizer A.,Maggio F.,Magri F.,Mangiameli S.,Marasco S.,Marchetti M.,Marrazza B.,Melandri F.,Mondillo G.,Montagnani M.,Napoli C.,Neri G. F.,Orlandi M.,Pantaleoni M.,Papa A.,Perrella G.,Pileggi V.,Pilleri G. P.,Pittalis M.,Piva M.,Resta F.,Rodari T.,Savastano A.,Savona M.,Sensi S.,Sorrentino F.,Squadrito S.,Stocchiero C.,Stranieri A.,Susco G.,Tani F.,Tassone F.,Taverniti R.,Terrosu P. F.,Tirella G.,Vicario A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine,Pharmacology (medical)
Reference45 articles.
1. Arntz H-R, Bonner G, Kikis D, Kirch W, Klor HU, et al. Efficacy of pravastatin and bezafibrate in primary hypercholesterolaemia. Deutsche Medizinische Wochenschrift 116: 7–12, 1991
2. Bailar JC III. Cause and effect in epidemiology. What do we know about hypertriglyceridemia. New England Journal of Medicine 302: 1417–1418, 1980
3. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azem SP, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. Journal of the American Medical Association 257: 3233–3240, 1987
4. Brown MS, Goldstein JL. Drugs used in the treatment of hyperlipoproteinemias. In Goodman & Gilman (Eds) The pharmacological basis of therapeutics, pp. 874–896, Pergamon Press 1990
5. Carmena R, de Oya M, Franco M, Martinez ML, Mata P, et al. Treatment of heterozygous familial hypercholesterolaemia with pravastatin (CS-514) and/or cholestyramine (The Spanish Multi-center Pravastatin Study). 8th International Symposium on Atherosclerosis, Rome, 9–13 October, pp. 757–760, 1988